Barclays PLC Acquires 24,355 Shares of Waldencast plc (NASDAQ:WALD)

Barclays PLC increased its holdings in shares of Waldencast plc (NASDAQ:WALD) by 301.4% during the 3rd quarter, HoldingsChannel reports. The firm owned 32,436 shares of the company’s stock after purchasing an additional 24,355 shares during the period. Barclays PLC’s holdings in Waldencast were worth $117,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Point72 Asia Singapore Pte. Ltd. lifted its holdings in shares of Waldencast by 293.9% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,854 shares of the company’s stock valued at $25,000 after purchasing an additional 5,114 shares in the last quarter. Catalina Capital Group LLC bought a new position in shares of Waldencast during the 3rd quarter valued at about $58,000. Milestones Administradora de Recursos Ltda. lifted its holdings in shares of Waldencast by 10.0% during the 3rd quarter. Milestones Administradora de Recursos Ltda. now owns 2,200,000 shares of the company’s stock valued at $8,008,000 after purchasing an additional 200,000 shares in the last quarter. McAdam LLC bought a new position in shares of Waldencast during the 3rd quarter valued at about $62,000. Finally, Bleakley Financial Group LLC lifted its holdings in shares of Waldencast by 75.2% during the 3rd quarter. Bleakley Financial Group LLC now owns 26,297 shares of the company’s stock valued at $96,000 after purchasing an additional 11,288 shares in the last quarter. Institutional investors own 41.97% of the company’s stock.

Analyst Ratings Changes

WALD has been the topic of a number of recent research reports. DA Davidson lifted their target price on Waldencast from $7.25 to $7.50 and gave the company a “buy” rating in a research report on Wednesday, December 4th. TD Cowen initiated coverage on Waldencast in a research report on Monday, December 16th. They issued a “hold” rating and a $4.30 target price on the stock. Canaccord Genuity Group lifted their target price on Waldencast from $5.00 to $6.00 and gave the company a “buy” rating in a research report on Friday, November 22nd. Telsey Advisory Group reissued an “outperform” rating and issued a $6.00 target price on shares of Waldencast in a research report on Monday, November 18th. Finally, Canaccord Genuity Group initiated coverage on Waldencast in a research report on Friday, October 25th. They issued a “buy” rating and a $5.00 target price on the stock. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $5.76.

Waldencast Stock Performance

NASDAQ:WALD opened at $3.15 on Thursday. Waldencast plc has a twelve month low of $2.40 and a twelve month high of $11.00. The stock’s 50 day moving average price is $3.51 and its two-hundred day moving average price is $3.46. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.21.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.